NCT05720091View on ClinicalTrials.gov

Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 14, 2023

Primary Completion Date

March 20, 2023

Study Completion Date

July 25, 2023

Conditions
Influenza, Human
Interventions
DRUG

ZX-7101A 80mg

a drug to treatment influenza in Chinese adults

Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University, Suzhou

Sponsors
All Listed Sponsors
lead

Nanjing Zenshine Pharmaceuticals

INDUSTRY